Chime prices IPO at $27 per share, valuing fintech company at $11.6 billion ahead of Nasdaq debut
Chime priced its IPO at $27 per share on Wednesday, above the expected range, in an offering that values the provider of online banking services at $11.6 billion
The company raised roughly $700 million in the IPO, with another $165 million worth of shares being sold by existing investors. The stock is expected to begin trading Thursday under ticker symbol CHYM.
The offering comes after a years-long freeze in the fintech IPO pipeline, as rising interest rates and valuation resets kept many late-stage companies on the sidelines. The market has started to loosen. Trading platform eToro jumped 29% in its Nasdaq debut last month, and crypto company Circle popped after hitting the market last week.
Online lender Klarna, meanwhile, has delayed its IPO plans and last month reported steep quarterly losses.
Chime's decision to go public — even after a steep cut from its last private valuation of $25 billion — marks a major test of investor appetite for consumer-facing finance companies. SoftBank, Tiger Global, and Sequoia all invested in the 2021 round at Chime's private market peak.
The company's top institutional shareholders are DST Global and Crosslink Capital, which owned 17% and 9.5%, respectively, of shares before the offering.
Chime's core business — offering no-fee banking services, debit cards, and early paycheck access — draws most of its revenue from interchange fees. The company competes in various areas with fintech incumbents PayPal, Square and SoFi.
Revenue in the latest quarter climbed 32% from a year earlier to $518.7 million. Net income narrowed to $12.9 million from $15.9 million a year ago.
Morgan Stanley, Goldman Sachs and JPMorgan Chase are leading the IPO.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
Viking Therapeutics, Inc. (VKTX) closed at $28.59 in the latest trading session, marking a -1.26% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.38%. On the other hand, the Dow registered a gain of 0.24%, and the technology-centric Nasdaq increased by 0.24%. Prior to today's trading, shares of the company had gained 8.96% outpaced the Medical sector's gain of 4.64% and the S&P 500's gain of 6.6%. The investment community will be paying close attention to the earnings performance of Viking Therapeutics, Inc. in its upcoming release. The company is expected to report EPS of -$0.44, down 120% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.86 per share and revenue of $25 million, indicating changes of -84.16% and 0%, respectively, compared to the previous year. Investors should also note any recent changes to analyst estimates for Viking Therapeutics, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Right now, Viking Therapeutics, Inc. possesses a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 74, which puts it in the top 31% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viking Therapeutics, Inc. (VKTX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Starbucks (SBUX) Stock Slides as Market Rises: Facts to Know Before You Trade
Starbucks (SBUX) closed the most recent trading day at $94.32, moving -1.12% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, the Dow experienced a rise of 0.24%, and the technology-dominated Nasdaq saw an increase of 0.24%. Heading into today, shares of the coffee chain had gained 10.23% over the past month, outpacing the Retail-Wholesale sector's gain of 2.95% and the S&P 500's gain of 6.6%. Analysts and investors alike will be keeping a close eye on the performance of Starbucks in its upcoming earnings disclosure. The company is predicted to post an EPS of $0.66, indicating a 29.03% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $9.29 billion, indicating a 1.94% upward movement from the same quarter last year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $2.53 per share and revenue of $36.89 billion, indicating changes of -23.56% and +1.97%, respectively, compared to the previous year. Investors should also pay attention to any latest changes in analyst estimates for Starbucks. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 1.46% decrease. At present, Starbucks boasts a Zacks Rank of #4 (Sell). Digging into valuation, Starbucks currently has a Forward P/E ratio of 37.67. For comparison, its industry has an average Forward P/E of 23.8, which means Starbucks is trading at a premium to the group. We can additionally observe that SBUX currently boasts a PEG ratio of 4.79. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Retail - Restaurants industry had an average PEG ratio of 2.53. The Retail - Restaurants industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 178, putting it in the bottom 28% of all 250+ industries. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Starbucks Corporation (SBUX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
This Incredibly Cheap Artificial Intelligence (AI) Chip Stock Wants to Become the Next Broadcom
Broadcom is currently the leading player in the market for custom AI processors, but it's about to get a new competitor very soon. This competitor recently announced its intention to re-enter the data center chip market, and it just made a move to ensure that it can make a dent. The other catalysts that this company is sitting on, along with its cheap valuation, make it an attractive buy right now. 10 stocks we like better than Qualcomm › Broadcom has become one of the leading players in the artificial intelligence (AI) semiconductor market thanks to its expertise in application-specific integrated circuits (ASICs), which are custom processors designed for performing specific tasks. The demand for these custom processors has been improving rapidly because of their ability to tackle AI workloads while keeping a handle on costs. As a result, several cloud hyperscalers are tapping Broadcom's custom chips and networking components to lower operating costs when running AI training and inference applications. This explains why Broadcom's growth has been outstanding in recent quarters. Moreover, a massive addressable revenue opportunity in the range of $60 billion to $90 billion suggests that it is at the beginning of a solid growth curve. Not surprisingly, even Qualcomm (NASDAQ: QCOM) wants a piece of this lucrative opportunity, and it has just made a move that could help it make a dent in the custom AI chip market. Qualcomm has just announced that it is set to acquire British chip company Alphawave Semi for $2.4 billion with the aim to "further accelerate, and provide key assets for, Qualcomm's expansion into data centers." Alphawave's technology will allow Qualcomm to integrate high-speed connectivity into its AI chip platforms to enable rapid data transfer, which will in turn lead to higher computing performance and reduced power consumption. Qualcomm believes that Alphawave's "products form a part of the core infrastructure enabling next generation services in a wide array of high growth applications, including data centers, AI, data networking and data storage." The chipmaker announced last month that it is set to reenter the data center market. The company is reportedly developing a custom AI chip platform using its Oryon central processing unit (CPU) and Hexagon neural processing unit (NPU) processors, which it claims are capable enough to meet AI inferencing workloads in data centers. The latest acquisition is another piece of the puzzle as Qualcomm gears up for the launch of a data center-focused chip platform. The company has already announced that it is partnering with Saudi Arabia-backed AI venture HUMAIN to build AI data centers in that country, suggesting that Qualcomm could get a foot in the door and eventually make its presence felt in the huge custom AI processor market. Importantly, there is space for another player in this market which is currently dominated by Broadcom with an estimated share of 70%. Marvell Technology controls the rest of this market. So, if Qualcomm can develop a cutting-edge product, it could end up becoming the third player here. That could give its business a big boost in the long run, considering the end-market opportunity on offer. Qualcomm currently gets its revenue from selling chips that go into three product lines -- handsets, automotive, and the Internet of Things (IoT). All these segments are benefiting from the proliferation of AI. This explains why Qualcomm's top line in the second quarter of fiscal 2025 jumped 15% year over year to $10.8 billion, while adjusted earnings shot up 17% year over year. The adoption of AI across these three markets is set to grow at a healthy pace. For example, AI adoption in the automotive market could grow at an annual rate of 37% over the next decade, while generative AI shipments are expected to increase at an annual rate of 78% through 2028. If Qualcomm is able to add another growth driver to its portfolio in the form of data centers, it won't be surprising to see it growing at a stronger pace in the long run. That's why buying Qualcomm stock right now could turn out to be a smart thing to do, as it is trading at just 15 times trailing earnings. Before you buy stock in Qualcomm, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Qualcomm wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,871!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $875,479!* Now, it's worth noting Stock Advisor's total average return is 998% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Qualcomm. The Motley Fool recommends Broadcom and Marvell Technology. The Motley Fool has a disclosure policy. This Incredibly Cheap Artificial Intelligence (AI) Chip Stock Wants to Become the Next Broadcom was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
